Herborium Group, Inc.
HBRM · OTC
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.1% | -1.2% | 7.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 63% | 55.8% | 62% | 63% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -27.4% | 17.6% | -23.2% | -26.8% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -31.3% | 2.6% | -23.6% | -31.3% |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | $0 | -$0 | $0 |
| Capital Expenditures | – | -$0 | -$0 | -$0 |
| Free Cash Flow | – | $0 | -$0 | $0 |